Compare VVPR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VVPR | NMTC |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.2M | 43.7M |
| IPO Year | 2016 | N/A |
| Metric | VVPR | NMTC |
|---|---|---|
| Price | $2.28 | $0.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | ★ 437.6K | 361.9K |
| Earning Date | 09-02-2023 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $61,000.00 | ★ $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $32.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 281.25 | 250.35 |
| 52 Week Low | $0.62 | $0.40 |
| 52 Week High | $8.88 | $1.39 |
| Indicator | VVPR | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 54.36 |
| Support Level | $2.12 | $0.85 |
| Resistance Level | $2.50 | $0.92 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 19.31 | 21.01 |
Vivopower International PLC is a sustainable energy solutions B Corporation specializing in electric solutions for customized and ruggedized fleet applications, battery and microgrids, solar, and critical power technology and services. The company's core purpose is to provide turnkey decarbonization solutions that help customers progress toward net-zero carbon status. VivoPower operates across five reportable segments: Electric Vehicles, Sustainable Energy Solutions, Solar Development, Digital Assets, and Corporate Office, with personnel and operations in Australia, the Netherlands, the United Kingdom, the United States, and the Philippines.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.